- RBM – www.rollbackmalaria.org - the Roll Back Malaria (RBM) Partnership was launched in 1998 by the World Health Organization (WHO), the United Nations Children’s Fund (UNICEF), the United Nations Development Programme (UNDP) and the World Bank to provide a coordinated global approach to fighting malaria.
- WHO – www.who.int/en/ - WHO is the directing and coordinating authority for health within the United Nations system. It is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries and monitoring and assessing health trends.
- MMV – www.mmv.org - Medicines for Malaria Venture (MMV) is a non-profit organization created to discover, develop and deliver effective and affordable antimalarial drugs through public-private partnerships.
- Novartis.com – www.novartis.com - Novartis’ aim is to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life. Throughout the years, Novartis and its predecessor companies have discovered and developed many innovative products for patients and consumers worldwide.
MAP - http://www.map.ox.ac.uk/ - The Malaria Atlas Project assembles medical intelligence and survey data to provide evidence-based maps on the distribution of malaria risk, human population, disease burdens, mosquito vectors, inherited blood disorders and malaria financing and control worldwide.
1 WHO Malaria Factsheet No. 94 Updated January 2009. Available at: http://www.who.int/mediacentre/factsheets/fs094/en/index.html